Cite
HARVARD Citation
Huhn, G. et al. (2017). A Randomized, Open-Label Trial to Evaluate Switching to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Plus Darunavir in Treatment-Experienced HIV-1-Infected Adults. Journal of acquired immune deficiency syndromes. p. . [Online].